Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 15,041 | 4,010 | 5,584 | 0 |
| Operating Income | -15,041 | -4,010 | -5,584 | N/A |
| Interest Expense | 1 | 0 | 27 | 0 |
| Other Income | 0 | -17,210 | 180 | 0 |
| Pre-tax Income | -15,042 | -21,220 | -5,431 | 0 |
| Net Income Continuous | -15,042 | -21,220 | -5,431 | N/A |
| Net Income | $-15,042 | $-21,220 | $-5,431 | $N/A |
| EPS Basic Total Ops | -1.28 | -1.95 | -0.50 | N/A |
| EPS Basic Continuous Ops | -1.28 | -1.95 | -0.50 | N/A |
| EPS Diluted Total Ops | -1.28 | -1.95 | -0.50 | N/A |
| EPS Diluted Continuous Ops | -1.28 | -1.95 | -0.50 | N/A |
| EBITDA(a) | $-15,041 | $-4,010 | $-5,584 | $N/A |